[ 메디채널 김갑성 기자 ] - Reinforcing Commitment to Preventive Cardiovascular and Home Blood Pressure Monitoring - KYOTO, Japan, Sept. 29, 2025 -- OMRON HEALTHCARE Co., Ltd., a global leader in innovative medical equipment for preventive healthcare, announced that cumulative worldwide sales of OMRON blood pressure monitors (BPMs) have exceeded 400 million units. This landmark achievement underscores the company's longstanding commitment to extending healthy life expectancy by advancing home blood pressure monitoring and preventive cardiovascular care. Logo: https://cdn.kyodonewsprwire
BANDAR SERI BEGAWAN, Brunei, Sept. 29, 2025 -- Over 2,000 residents across all age groups converged at BIBD Connects, Taman Mahkota Jubli Emas, Bandar Seri Begawan, on 28 September 2025 as the Ministry of Health officially launched a five-month nationwide health campaign aimed at combating sedentary lifestyles and promoting preventive healthcare across the nation. The BN on the Move Championship 2025 will run through February 2026 with monthly challenges and lucky draws designed to sustain participation among the 400,000 Bruneians already using the BruHealth application.
LONDON, ROME and ZUG, Switzerland, Sept. 29, 2025 -- Global pharma major Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN), today announced its wholly owned subsidiary, Nanomi B.V. ('Nanomi'), has signed a definitive agreement for the acquisition of VISUfarma B.V. (VISUfarma), a portfolio company of global healthcare specialist investor GHO Capital Partners LLP (GHO). The acquisition of VISUfarma, with its broad portfolio of innovative eye health products and established commercial infrastructure, aligns with Lupin's strategy to expand its Europea
[ 메디채널 김갑성 기자 ] Viva Biotech is acknowledged for its pioneering AI-driven drug discovery platforms that accelerate timelines, reduce costs, and expand therapeutic innovation in the global pharmaceutical R&D ecosystem. SAN ANTONIO, Sept. 29, 2025 -- Frost & Sullivan is pleased to announce that Viva Biotech has been given the 2025 APAC Technology Innovation Leadership recognition in the Integrated Intelligent Drug Discovery industry for its outstanding achievements in driving transformative efficiencies in preclinical research and development. This recognition highlights Viva B
BANGKOK, Sept. 29, 2025 -- Chula ARi, an interdisciplinary initiative by Chulalongkorn University, addresses the challenges of Thailand's rapidly aging society by using research to develop comprehensive elderly care models across economic, social, health, environmental, and innovation dimensions. The project also encourages pre-senior citizens to prepare for future aging challenges. Thailand is approaching a "senior tsunami," with the population aged 60 and above expected to rise from 20% to 30% within the next decade, transforming the nation into a super-aged society
[ 메디채널 김갑성 기자 ] 방콕 2025년 9월 29일 -- 쭐랄롱꼰 대학교가 추진하는 학제 간 이니셔티브인 쭐라 ARi(Chula ARi)는 고령화 사회로 빠르게 진입하고 있는 태국이 직면한 다양한 과제를 해결하기 위해 경제, 사회, 건강, 환경, 혁신 차원을 아우르는 포괄적인 노인 돌봄 모델 개발을 위한 연구를 진행하고 있다. 이 프로젝트는 또한 고령화로 인해 예비 고령층이 미래에 겪게 될 문제에 대비할 수 있도록 장려한다. 태국은 향후 10년 이내 60세 이상 인구 비율이 현재의 20%에서 30%로 올라가며 초고령 사회에 진입할 것으로 예상된다. 즉 '고령화 쓰나미(senior tsunami)'가 몰려오게 되는 것이다. 쭐라 ARi 책임자인 비판 프라추암모(Vipan Prachuabmoh) 교수(박사)는 1963~1983년 사이에 태어난 대규모 인구 집단이 매년 약 100만 명씩 신규 고령층으로 편입된다는 점을 지적한다. 이들의 기대 수명은 길어졌지만, 만성 질환에 걸리거나 의존이 필요한 사람이 증가하면서 사회•복지적 부담이 커지고 있다는 설명이다. 2018년 C2F 기금으로 출범한 쭐라 ARi는 태국 노인
140,000 documents transformed into 60,000 structured records since go-live SYDNEY, Sept. 29, 2025 -- Newgen Software, a global provider of an AI-first unified digital transformation platform, announced that Macquarie University Health has successfully gone live with Newgen's Content Management and Process Automation Platform to modernise patient document processing. Leveraging Newgen's AI-first Contextual Content Services (ECM) and Intelligent Process Automation (BPM) Platforms, the Sydney-based healthcare firm revamped records management across its hospital network. AI
HONG KONG, Sept. 29, 2025 -- Since 2025, the medical and healthcare sector have become a hot investment target in Hong Kong capital market. According to the Hang Seng Index Company, the healthcare industry has surged by as much as 91.2% from the beginning of the year until late August, making it the best-performing sector among the 12 industry indices of the Hang Seng Composite Index. Among healthcare-related stocks, Home Control(1747.HK) has shown strong growth potential following its expansion from smart home IoT to home medical fields, backed by its solid background of experiences in Europ
BEIJING, Sept. 28, 2025 -- A news report from Xinhua Finance, "Over the past few years, we have seen China gradually increase its universal health coverage, boost investment, and place great emphasis on preventive medicine. While advancing its 'Healthy China 2030' initiative, China has built a high-quality healthcare system," said Martin Taylor, representative of the World Health Organization (WHO) in China. The WHO is very willing to collaborate with China, focusing on grassroots healthcare and the needs of the public to better meet the diagnostic and treatment needs concerning non
[ 메디채널 김갑성 기자 ] 타이베이, 2025년 9월 27일 -- 테스칸 그룹(Tescan Group)이 오늘 초고속 레이저 기술 분야를 선도하는 혁신 기업인 펨토이노베이션즈(FemtoInnovations)를 인수하고 코네티컷대학교 기술 단지(UConn Tech Park)에 레이저 기술 전담 사업부(LT BU)를 신설한다고 발표했다. 신생 사업부의 임무는 반도체, 생체 의료 기기 제조, 첨단 연구 분야를 겨냥한 테스칸의 상관관계 분석 및 다중 모드 포트폴리오를 확장하는 것이다. 펨토이노베이션즈 인수로 테스칸은 독창적이고 혁신적인 레이저 플랫폼을 확보하게 되었다. 이 플랫폼은 이미 까다로운 워크플로에서 검증을 마쳤고, 반도체, 첨단 제조, 첨단 기술 산업 분야를 이끄는 다국적 기업들로부터 지대한 관심을 받고 있다. 테스칸 그룹의 장샤를 첸(Jean-Charles Chen) 최고경영자(CEO)는 "펨토이노베이션즈가 테스칸 패밀리에 합류한 것은 토털 워크플로 솔루션 기술력을 강화하려는 취지에서 내린 전략적 결단이다. 초고속 레이저 마이크로머시닝(Laser Micromachining) 기술에 업계 최고를 다